PATENT CLAIM ANALYSIS

Application Number: 15744723
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "497000"]

Abstract:
Nanopaiticle compositions described herein comprise combinations of prodrugs of therapeutic agents that achieve enhanced therapeutic effects as compared to those observed when combinations of free forms of these therapeutic agents are administered.

Claim (Index 1):
A pharmaceutical composition including a set of pharmaceutical compositions comprising nanoparticles wherein said nanoparticles have an average diameter of less than 80 nm and comprise:\n a) at least two therapeutic agents, each therapeutic agent coupled through a linker to a hydrophobic moiety to form a prodrug, and b) an amphiphilic stabilizer comprising a hydrophobic portion and a hydrophilic portion wherein the weight ratio of the hydrophobic portion to the hydrophilic portion is in the range of 8:5 to 12:5 and wherein the hydrophobic portion has a molecular weight of 8 kD to 15 kD.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 86.0
- Lexical Diversity: 1.26923
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13363822', '13915049', '13478691', '13659460', '12485406']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7123656195065605
- 35 USC 102 Novelty (BERT): 0.4975913247116161
- Combined Prediction Score: 0.690888190027066
- Mean Citation Score: 237.994782
- Max Citation Score: 240.42374
- Similarity Product: 170.21221322962646

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test